Advertisement

Topics

Companies Related to "Prognostic value PAM50 risk recurrence score patients with" [Most Relevant Company Matches] RSS

00:42 EDT 19th October 2018 | BioPortfolio

Here are the most relevant search results for "Prognostic value PAM50 risk recurrence score patients with" found in our extensive corporate database of over 50,000 company records.

Showing "Prognostic value PAM50 risk recurrence score patients with" Companies 1–25 of 4,500+

Relevant

comScore, Inc.

comScore, Inc. (NASDAQ: SCOR) is a global leader in measuring the digital world and preferred source of digital marketing intelligence. For more information, please visit www.comscore.com/companyinfo.


Agendia BV

Agendia, located in Amsterdam, The Netherlands, is a world leader in gene expression analysis-based diagnostics with three products on the market. The company focuses on the development and commercialization of diagnostic tests using tumor gene expression profiling. Agendia was the first company to commercialize a prognostic test -- MammaPrint(R) -- that predicts the risk of breast cancer rec...

Front Seat

Walk Score is a project of Front Seat, a civic software company based in Seattle. Front Seat software connects people to the places we live, the resources we consume, and our communities. Since its launch in July 2007, Walk Score has become the most popular measure of walkability in the U.S., Canada, and the U.K., with more than two million addresses scored. The Walk Score team is advised by a...


ChipDX LLC

ChipDX develops and delivers novel multi-gene diagnostic and prognostic assays for oncology research use only. The aim of the company is to increase access to advanced, well-validated predictive and prognostic assays through collaborations with existing diagnostic service providers and also through its modular, online delivery system: www.ChipDX.com. Other ...

Score Group plc

Score Group plc is an international organisation, providing Clients with a worldwide around the clock range of engineering solutions. Available 24 hours a day, our technical sales and support staff are aided by teams of specialist engineers, and always on hand to assist our Clients with even the most difficult and urgent enquiries.Score services now include Intelligent Valve Management™, advance...

The Finnish Breast Cancer Group

The study, led by the Finnish Breast Cancer Group, was a large open-label, two-arm, randomised multicentre phase III study in women with early breast cancer. 1,500 patients in Finland and Sweden with no distant metastases who had an intermediate to high risk of recurrence within five years from the time of diagnosis, were recruited to the study.

DACOGEN

DACOGEN is indicated for treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British (FAB) subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and i...

Ask.com

Ask.com is an operating business of IAC (NYSE: IACI) and more than 50 million people visit Ask.com each month, where they are three times more likely to enter their searches in the form of a question than on any other search engine (comScore, March 2010). The Ask Network of sites is the 6th largest Internet property in the U.S., with more than 98 million domestic unique monthly users, according to...

Tethys Bioscience, Inc.

Tethys is a cardiometabolic diagnostics company that creates and commercializes breakthrough biomarker-based blood tests that predict imminent disease risk and enable targeted intervention to preempt the onset of chronic conditions such as type 2 diabetes. Tethys introduced its first product -- PreDx® Diabetes Risk Score -- to the market in 2008, and in...

Agendia, Inc.

Agendia is a privately owned, leading molecular diagnostic company that develops and markets FFPE-based genomic diagnostic products, which help support physicians with their complex treatment decisions. Agendia’s breast cancer suite was developed using an unbiased gene selection by analyzing the complete human genome. This includes FDA-cleared MammaPr...

Metamark Genetics, Inc.

Metamark is a privately held oncology company focused on the development of function-based prognostic assays for early staged cancers. The MetamarkDx(TM) Prognostic Assays under development are based on Metamark's proprietary Prognosis Determinants(TM), genes discovered through leading edge cancer research and demonstrated to play a causal role in promoting tumor progression and spread. For furthe...

bioTheranostics, Inc.

bioTheranostics discovers, develops, and commercializes a growing array of molecular diagnostic tests for cancer patients. Leveraging its unique expertise in expression profiling and algorithm development, bioTheranostics is well positioned to be a partner and solution provider in metastatic cancer. The company operates a CLIA-certified, CAP-accredited dia...

Castle Biosciences Inc.

Castle Biosciences is a molecular diagnostics and prognostics company dedicated to helping patients and physicians make optimal decisions regarding treatment and follow-up care based on the tumor’s unique molecular signature. The Company currently offers prognostic tests for patients with rare cancers including uveal and cutaneous melanoma, esophageal...

Turnstone Biologics

Turnstone Biologics is a clinical-stage, immuno-oncology company focused on the development of next-generation oncolytic viral immunotherapies for patients with a broad range of solid tumors. Turnstone’s unique, first-in-class oncolytic viral immunotherapies combine the potent tumor-killing effects of an oncolytic virus with a tumor-targeted T-cell va...

Priska

Priska™ is designed to provide assessment data associated with a patient’s risk for opioid abuse, as well as other mental health conditions. The Opioid Risk Tool assessment consists of a 5-question survey and fits each patient into one of three risk categories: low risk, moderate risk or high risk. The peer-reviewed tool is highly trusted and wid...

Walk Score

Genomic Health

Genomic Health gives cancer patients and physicians insight needed to help make quality treatment decisions. GenomicHealth.com is designed to help patients, caregivers and healthcare professionals understand how individualized genomic profiling of tumor tissue may help improve cancer management. The first diagnostic assay developed by Genomic Health — Oncotype DX™ — is a breast cancer test t...

IMPATH

IMPATH is in the business of improving outcomes for cancer patients. With a database of over 870,000 patient profiles, IMPATH uses sophisticated technologies to provide patient-specific diagnostic, prognostic and treatment information to more than 8,300 physicians specializing in the treatment of cancer patients, in over 2,000 hospitals and over 570 oncology practices. Utilizing its comprehensive ...

IMPATH-BCP

IMPATH is in the business of improving outcomes for cancer patients. With a database of over 870,000 patient profiles, IMPATH uses sophisticated technologies to provide patient-specific diagnostic, prognostic and treatment information to more than 8,300 physicians specializing in the treatment of cancer patients, in over 2,000 hospitals and over 570 oncology practices. Utilizing its comprehensive ...

The Risk Authority Stanford

The Risk Authority Stanford (TRA Stanford) is a healthcare risk management consulting firm dedicated to transforming its clients’ risk management practices with cutting-edge solutions, unrivaled expertise, and quantifiable results. TRA Stanford’s origins are rooted within the Stanford University Medical Network, and it continues to provide all ...

Life Time Pharmaceuticals Incorporated

LifeTime™ Pharmaceuticals, a private clinical-stage pharmaceutical company, focuses on the development of drugs that are safe enough for long-term, chronic administration. Compounds currently under development seek to eliminate and prevent recurrence of potentially fatal cancers and infectious syndromes. Human clinical trial results presented at several scientific meetings (see below) have shown...

International Chair on Cardiometabolic Risk

Based at Universite Laval, Quebec, Canada, the International Chair on Cardiometabolic Risk is made up of 25 world-renowned international scientists. Their goals are to develop awareness and knowledge around the cardiometabolic risk factors in order to improve international patient management. Each year, this group organizes a series of conferences and debates. The Chair also intends to provide ...

Origami Risk LLC

Origami Risk LLC was founded by industry veterans committed to designing intuitive web-based software that streamlines how risk, insurance and claims data is collected, analyzed and shared—ultimately helping users to be more productive and manage the total cost of risk for their organizations or for their clients. Origami Risk is consistently ranked b...

Dako Australia

makers of automated, predictive,diagnostic, and prognostic cancer systems.

The Risk Authority

The Risk Authority – Stanford (TRA) is an innovative healthcare risk management consulting firm dedicated to transforming their clients’ risk management practices with cutting-edge solutions, unrivaled industry expertise and quantifiable results. TRA’s origins are rooted within the Stanford University Medical Network. This connection continues toda...


More From BioPortfolio on "Prognostic value PAM50 risk recurrence score patients with"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks